Pharmaceutical Manufacturing Just Got An Automation Boost From IoT

810009

CEO of Phizzle, Ben Davis.

Phizzle

One of the trends that has emerged from the COVID-19 pandemic is the onshoring of U.S. pharmaceutical manufacturing. As more companies focus on manufacturing in the U.S., they face stringent requirements from the U.S. Food and Drug Administration (FDA) to meet cleanroom compliance, such as monitoring the particles in the air. 

To help pharmaceutical manufacturers with cleanroom compliance, Phizzle has introduced the EDGMaker digital air series, which is the first internet of things (IoT) solution to operate multi-vendor particle counters remotely. 

The Growth of Onshoring and Meeting FDA Compliance Standards 

The COVID-19 pandemic has forced companies to recognize the dangers of offshoring all of their pharmaceutical manufacturing during a crisis. Onshoring, the opposite of offshoring, focuses on relocating processes back inside national borders to reduce the risks associated with outsourcing, such as supply shortages, disruptions in supply chains, work interruptions, and importing problems.    

As more companies focus on manufacturing pharmaceuticals like COVID-19 vaccines and other drugs in the U.S., the growth of onshoring brings its own challenges…

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close